Wörns, M., & Schirmacher, P. (2017). Drug treatment for chronic hepatitis C infection and cancer risk: The effect of direct antivirals on the incidence and recurrence of hepatocellular carcinoma. Deutsches Ärzteblatt, 114(35/36), . https://doi.org/10.3238/arztebl.2017.0597
Chicago Style (17th ed.) CitationWörns, Marcus-Alexander, and Peter Schirmacher. "Drug Treatment for Chronic Hepatitis C Infection and Cancer Risk: The Effect of Direct Antivirals on the Incidence and Recurrence of Hepatocellular Carcinoma." Deutsches Ärzteblatt 114, no. 35/36 (2017). https://doi.org/10.3238/arztebl.2017.0597.
MLA (9th ed.) CitationWörns, Marcus-Alexander, and Peter Schirmacher. "Drug Treatment for Chronic Hepatitis C Infection and Cancer Risk: The Effect of Direct Antivirals on the Incidence and Recurrence of Hepatocellular Carcinoma." Deutsches Ärzteblatt, vol. 114, no. 35/36, 2017, https://doi.org/10.3238/arztebl.2017.0597.